The company will showcase a wave of transformative innovations designed to address the most pressing challenges in healthcare, spanning the care journey across smart devices and drugs throughout disease states enabled by cloud and AI solutions. GE HealthCare has invested more than $3B in R&D since 2022, delivering an innovation renaissance across disease states to … [Read more…]
SIGNA Bolt1, a new 3T MRI scanner, is designed with a next-gen gradient system engineered to support precision diagnostics, clinical efficiency, and advanced research capability. SIGNA Sprint with Freelium,2 a new sealed magnet MRI system, seeks to reimagine 1.5T MRI by combining a sustainable design with remarkable image quality, and operational autonomy to expand access … [Read more…]
LONDON–(BUSINESS WIRE)–#AIDS–In honour of World AIDS Day 2025, AIDS Healthcare Foundation (AHF) UK will host two community events to emphasize that the work to end HIV/AIDS is not over. The first commemoration will take place on Monday, 1 December, at the Croydon BME Forum Wellness Centre in the Whitgift Shopping Centre (1st Floor, CR0 1LP), … [Read more…]
LOS ANGELES–(BUSINESS WIRE)–In today’s digital dating world, conversations around sexual health are often avoided or treated as taboo. While some mainstream dating platforms have begun encouraging users to disclose their sexual health before meeting, many companies still hesitate to associate their brand with topics such as herpes and other STDs. However, PositiveSingles has chosen a … [Read more…]
M.O.U. cements Bangladesh as AIDS Healthcare Foundation’s newest country Global nonprofit cares for over 2.7 million people worldwide; adds Tennessee and Michigan to U.S. roster LOS ANGELES–(BUSINESS WIRE)–To mark World AIDS Day 2025, AIDS Healthcare Foundation (AHF) will hold major commemorative concerts and events in early December across Africa, Asia, Europe, and the Americas to … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “CAR T-Cell Therapy for Multiple Myeloma Market – A Global and Regional Analysis: Focus on Product, End User, and Region – Analysis and Forecast, 2025-2035” has been added to ResearchAndMarkets.com’s offering. The chimeric antigen receptor (CAR) T-cell therapy has emerged as a groundbreaking treatment modality, offering new hope for patients with relapsed or … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Biological Evaluation of Medical Devices Training Course (Jan 21st – Jan 22nd, 2026)” training has been added to ResearchAndMarkets.com’s offering. Ensure compliance with the ISO 10993 series of standards for the biological evaluation of medical devices, as it is well-established and expected by regulatory authorities worldwide. In the European Union, compliance with these … [Read more…]
LOS ANGELES–(BUSINESS WIRE)–#EndAIDS–In honor of World AIDS Day 2025, AIDS Healthcare Foundation (AHF) will hold major commemorative concerts and events in early December across Africa, Asia, Europe, and the Americas to emphasize that the work to end HIV/AIDS is far from over—underscored by the 1.3 million new infections that still occur globally each year. This … [Read more…]
Eydenzelt® a biosimilar referencing Eylea®, receives a Notice of Compliance from Health Canada (aflibercept 2mg) The approval is based on the totality of evidence, including analytical, nonclinical, and clinical data from global Phase III studies demonstrating Eydenzelt is similar in efficacy and safety for all approved indications Celltrion expands its biosimilars portfolio into ophthalmology reinforcing … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Paracetamol (CAS 103-90-2) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. This report on Paracetamol provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological details, along with transport information. This in-depth study serves … [Read more…]
